Properties of amorphous silica nanoparticles colloid drug delivery system synthesized using the micelle formation method
Source abstract
Abstract
This study describes the formation and properties of a silica nanocolloid drug delivery system synthesized using micelle formation method. Previously, we have reported feasibility of using the same approach to entrap colorless water soluble drug (isoniazid). However, the entrapment of the drug inside nanoparticles (NPs) could not be observed due to its colorless nature. In this study, poor water soluble Rifampicin (RIF) was used as a drug model. Orange color of RIF enables observation and measurement using UV–Vis spectrophotometer. Several parameters were systematically studied: reaction temperature (25–70 °C) produced 28–97 nm, amount of surfactant (4–9 g) produced 44–66 nm, butanol volume (6–18 ml) produced 50–157 nm, and drug concentration. Particle size could be tuned from 28 to 157 nm by varying synthesis parameters. NP size was highly influenced by reaction temperature and butanol. Silica nanocolloid-entrapped RIF (50 and 70 nm SiRif) were synthesized and further analyzed for biological application. The stability of SiRif in biological media, such as in 0.1, 0.5, and 1.0 M NaCl solution and 5, 10, and 25 % mouse serum, was examined. RIF was successfully entrapped inside silica nanocolloids. Moreover, 50 and 70 nm SiRif exhibited almost similar stability in NaCl and mouse serum. The drug release profiles in 0.1 and 1.0 mM phosphate buffer solutions and different pH at 37 °C were examined for several days. Results indicate that 70 nm SiRif had higher drug loading and slower release profile than 50 nm SiRif. 70 nm SiRif was optimally released at pH 6.8.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Surfactants and Colloidal Systems · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Abarkan I, Doussineau T (2006) Tailored macro/microstructural properties of colloidal silica nanoparticles via microemulsion preparation. Polyhedron 25(8):1763–177010.1016/j.poly.2005.11.031 ↗
2. Arriagada F, Osseo-Asare K (1999) Synthesis of nanosize silica in a nonionic water-in-oil microemulsion: effects of the water/surfactant molar ratio and ammonia concentration. J Colloid Interface Sci 211(2):210–22010.1006/jcis.1998.5985 ↗
3. Bagwe RP et al (2004) Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir ACS J Surf Colloids 20(19):8336–834210.1021/la049137j ↗
4. Balakrishnan V, Ab Wab HA, Abdul Razak K, Shamsuddin S (2013) In vitro evaluation of cytotoxicity of colloidal amorphous silica nanoparticles designed for drug delivery on human cell lines. J Nanomater. doi: 10.1155/2013/729306
5. Barbé CJ et al (2008) Sol–gel matrices for controlled release: from macro to nano using emulsion polymerisation. J Sol–Gel Sci Technol 46(3):393–40910.1007/s10971-008-1721-4 ↗
6. Chen R et al (2012a) Controlled release of small molecules from silica xerogel with limited nanoporosity. J Mater Sci Mater Med 24(1):137–14610.1007/s10856-012-4783-3 ↗
7. Chen Z et al (2012b) Mesoporous silica nanoparticles with manipulated microstructures for drug delivery. Colloids Surf B 95:274–27810.1016/j.colsurfb.2012.03.012 ↗
8. Cui Z-G et al (2010) Effects of surfactant structure on the phase inversion of emulsions stabilized by mixtures of silica nanoparticles and cationic surfactant. Langmuir ACS J Surf Colloids 26(7):4717–472410.1021/la903589e ↗
9. Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17(8):2950–296210.1016/j.bmc.2009.02.043 ↗
10. Fuertes AB, Valle-Vigón P, Sevilla M (2010) Synthesis of colloidal silica nanoparticles of a tunable mesopore size and their application to the adsorption of biomolecules. J Colloid Interface Sci 349(1):173–18010.1016/j.jcis.2010.05.041 ↗
11. Fujiwara M, Shiokawa K (2004) Preparation and formation mechanism of silica microcapsules (hollow sphere) by water/oil/water interfacial reaction. Chem Mater 16(23):5420–542610.1021/cm048804r ↗
12. Gangadhar KN et al (2012) Phase behavior of Rifampicin in cholesterol-based liquid crystals and polyethylene glycol. Eur J Pharm Sci Off J Eur Fed Pharm Sci 47(5):804–812
13. Gordon S, Teichmann E, Young K (2010) In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery. Eur J Pharm Sci 41(2):360–36810.1016/j.ejps.2010.07.004 ↗
14. Guo J et al (2008) Size-controllable synthesis of monodispersed colloidal silica nanoparticles via hydrolysis of elemental silicon. J Colloid Interface Sci 326(1):138–14210.1016/j.jcis.2008.07.020 ↗
15. Hajarul AAW et al (2011) Properties of amorphous silica entrapped isoniazid drug delivery system. Adv Mater Res 364:134–13810.4028/www.scientific.net/AMR.364.134 ↗
16. Hajarul AAW et al (2013) The effect of amount of surfactant and types of drug on amorphous silica drug delivery system (DDS). Adv Mater Res 620:112–11610.4028/www.scientific.net/AMR.620.112 ↗
17. He Q et al (2009) Size-controlled synthesis of monodispersed mesoporous silica nano-spheres under a neutral condition. Microporous Mesoporous Mater 117(3):609–616. http://linkinghub.elsevier.com/retrieve/pii/S1387181108003946 . Accessed 2 April 201210.1016/j.micromeso.2008.08.004 ↗
18. He Q et al (2010a) An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 31(12):3335–3346. http://www.ncbi.nlm.nih.gov/pubmed/20106517 . Accessed 12 July 201210.1016/j.biomaterials.2010.01.015 ↗
19. He C et al (2010b) Templated silica with increased surface area and expanded microporosity: synthesis, characterization, and catalytic application. Chem Eng J 162(3):901–90910.1016/j.cej.2010.06.037 ↗
20. Hershfield E (1999) Tuberculosis 9. Treatment. Can Med Assoc J 161(4):405–411
21. Hwang Y-J, Oh C, Oh S-G (2005) Controlled release of retinol from silica particles prepared in O/W/O emulsion: the effects of surfactants and polymers. J Control Release Off J Control Release Soc 106(3):339–34910.1016/j.jconrel.2005.05.007 ↗
22. Jia Z et al (2011) A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. Eur J Pharm Biopharm 79(1):126–13410.1016/j.ejpb.2011.05.009 ↗
23. Jung CY et al (2012) One-pot synthesis and surface modifications of organically modified silica (ORMOSIL) particles having multiple functional groups. J Colloid Interface Sci 367(1):67–7310.1016/j.jcis.2011.09.016 ↗
24. Kim T, Chung P, Lin V (2010) Facile synthesis of monodisperse spherical MCM-48 mesoporous silica nanoparticles with controlled particle size. Chem Mater 22(17):5093–510410.1021/cm1017344 ↗
25. Knopp D, Tang D, Niessner R (2009) Review: bioanalytical applications of biomolecule-functionalized nanometer-sized doped silica particles. Anal Chim Acta 647(1):14–3010.1016/j.aca.2009.05.037 ↗
26. Li J et al (2010) In vitro drug release study of methacrylate polymer blend system: effect of polymer blend composition, drug loading and solubilizing surfactants on drug release. J Mater Sci Mater Med 21(2):583–58810.1007/s10856-009-3899-6 ↗
27. Lin Y, Abadeer N, Haynes C (2011) Stability of small mesoporous silica nanoparticles in biological media. Chem Commun 47:532–53410.1039/C0CC02923H ↗
28. Lin Y-S, Hurley KR, Haynes CL (2012) Critical considerations in the biomedical use of mesoporous silica nanoparticles. J Phys Chem Lett 3:364–37410.1021/jz2013837 ↗
29. Lopez T, Ortiz E, Alexander-Katz R (2009) Cortisol controlled release by mesoporous silica. Nanomed Nanotechnol Biol Med Biol Med 5(2):170–17710.1016/j.nano.2008.08.002 ↗
30. Mehta S, Kaur G, Bhasin K (2009) Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies. J Pharm Sci 99(4):1896–191110.1002/jps.21971 ↗
31. Min L et al (2005) Functionalized fluorescein-doped SiO2 nanoparticles for immunochromatographic assay. Chin J Chem 23:875–88010.1002/cjoc.200590875 ↗
32. Napierska D et al (2010) The nanosilica hazard: another variable entity. Part Fibre Toxicol 7(39):1–32
33. Nieto A et al (2009) Cell viability in a wet silica gel. Acta Biomater 5(9):3478–348710.1016/j.actbio.2009.05.033 ↗
34. Orts-Gil G et al (2010) Characterisation of silica nanoparticles prior to in vitro studies: from primary particles to agglomerates. J Nanopart Res 13(4):1593–160410.1007/s11051-010-9910-9 ↗
35. Owen SC, Chan DPY, Shoichet MS (2012) Polymeric micelle stability. Nano Today 7(1):53–6510.1016/j.nantod.2012.01.002 ↗
36. Pandey R et al (2003) Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis 83(6):373–37810.1016/j.tube.2003.07.001 ↗
37. Parida SK et al (2006) Adsorption of organic molecules on silica surface. Adv Colloid Interface Sci 121(1–3):77–11010.1016/j.cis.2006.05.028 ↗
38. Rahman IA et al (2009) Size-dependent physicochemical and optical properties of silica nanoparticles. Mater Chem Phys 114(1):328–33210.1016/j.matchemphys.2008.09.068 ↗
39. Rosenholm JM, Sahlgren C, Linden M (2010) Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles—opportunities and challenges. Nanoscale Res Lett 2:1870–188310.1039/c0nr00156b ↗
40. Roy I et al (2003) Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125(26):7860–786510.1021/ja0343095 ↗
41. Santra S et al (2001) Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir 17(10):2900–290610.1021/la0008636 ↗
42. Singh S et al (2001) A critical review of the probable reasons for the poor variable bioavailability of Rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. Int J Pharm 228(1–2):5–1710.1016/S0378-5173(01)00754-2 ↗
43. Sosnik A et al (2010) New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev 62(4):547–55910.1016/j.addr.2009.11.023 ↗
44. Strømme M et al (2009) Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. Focus Artic 1:140–148
45. Tabatabaei S (2006) Experimental study of the synthesis and characterisation of silica nanoparticles via the sol–gel method. J Phys Conf Ser 26:371–37410.1088/1742-6596/26/1/090 ↗
46. Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release Off J Control Release Soc 73(2–3):137–17210.1016/S0168-3659(01)00299-1 ↗
47. Tourne-Peteilh C et al (2012) Sol–gel one-pot synthesis in soft conditions of mesoporous silica materials ready for drug delivery system. J Sol–Gel Sci Technol 61:455–46210.1007/s10971-011-2646-x ↗
48. Trewyn BG et al (2008) Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem Eng J 137(1):23–2910.1016/j.cej.2007.09.045 ↗
49. Trofymluk O, Levchenko A, Navrotsky A (2012) Mesoporous silica synthesis: energetics of interaction between framework and structure directing agent. Microporous Mesoporous Mater 149(1):119–12510.1016/j.micromeso.2011.08.022 ↗
50. Vaishali G, Mangesh B, Makarand G (2010) Development of rifampicin nanoparticles by 32 factorial design. Int J Pharm Sci Nanotechnol 3(3):1085–1091
51. Wang S (2009) Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater 117(1–2):1–9
52. Wang JG et al (2008) Anionic surfactant-templated mesoporous silica (AMS) nano-spheres with radially oriented mesopores. J Colloid Interface Sci 323(2):332–33710.1016/j.jcis.2008.04.044 ↗
53. Wang W et al (2009) Effect of alcohol on morphology and mesostructure control of anionic-surfactant-templated mesoporous silica (AMS). J Colloid Interface Sci 331(1):156–16210.1016/j.jcis.2008.11.024 ↗
54. Wang J et al (2010) Preparation of anisotropic silica nanoparticles via controlled assembly of presynthesized spherical seeds. Langmuir 26(23):18491–1849810.1021/la103564p ↗
55. Wanyika H et al (2011) Synthesis and characterization of ordered mesoporous silica nanoparticles with tunable physical properties by varying molar composition of reagents. Afr J Pharm Pharmacol 5(21):2402–2410
56. Wu S-H, Hung Y, Mou C-Y (2011) Mesoporous silica nanoparticles as nanocarriers. Chem Commun 47(36):9972–998510.1039/c1cc11760b ↗